Europe Must Not Squander Potential Of Reformulation
Pharmanovia And Medicines For Europe Executive Makes Case For Inclusion In Legislation
At a panel on value added medicines at Medicines for Europe’s 30th annual conference in Dublin last week, Pharmanovia CEO and value added medicines sector chair James Burt set out the case for expanding the scope of current EU pharma legislation proposals to reward reformulation alongside repurposing.
